Nose-to-brain delivery of temozolomide-loaded PLGA nanoparticles functionalized with anti-EPHA3 for glioblastoma targeting

Glioblastoma is the most common malignant brain tumor. Efficient delivery of drugs targeting glioblastomas remains a challenge. Ephrin type-A receptor 3 (EPHA3) tyrosine kinase antibody-modified polylactide-co-glycolide (PLGA) nanoparticles (NPs) were developed to target glioblastoma via nose-to-bra...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Liuxiang, Wang, Aiping, Ni, Ling, Yan, Xiuju, Song, Yina, Zhao, Mingyu, Sun, Kaoxiang, Mu, Hongjie, Liu, Sha, Wu, Zimei, Zhang, Chunyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127843/
https://www.ncbi.nlm.nih.gov/pubmed/30176744
http://dx.doi.org/10.1080/10717544.2018.1494226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127843/
https://www.ncbi.nlm.nih.gov/pubmed/30176744
http://dx.doi.org/10.1080/10717544.2018.1494226

Ejemplares similares